来源:视频滚动新闻
杰富瑞:将月湖(Moonlake)免疫疗法公司评级从“买入”下调至“持有”,目标价从65美元下调至8美元。注:因公司一款实验性皮肤病药物的晚期临床试验数据不及预期,隔夜公司股价暴跌90%。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.